Cargando…
Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention
BACKGROUND: Recently, sclerostin, a bone-derived protein, has been shown to play a key role in atherosclerosis progression. However, few studies have investigated the influence of sclerostin on cardiovascular disease prognosis. We investigated the relationship between serum sclerostin levels and adv...
Autores principales: | He, Wuyang, Li, Chunqiu, Chen, Qingwei, Xiang, Tingting, Wang, Peng, Pang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532957/ https://www.ncbi.nlm.nih.gov/pubmed/31677125 http://dx.doi.org/10.1007/s40520-019-01393-2 |
Ejemplares similares
-
Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021) -
Changes in serum serotonin levels in patients with acute coronary
syndrome and stable angina undergoing percutaneous coronary
intervention
por: Han, Donghoon, et al.
Publicado: (2020) -
Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease
por: Wester, Michael, et al.
Publicado: (2022) -
Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention
por: Suzuki, Sho, et al.
Publicado: (2019) -
Impact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Wang, Kai, et al.
Publicado: (2022)